Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › IBIO

SILVERARC CAPITAL MANAGEMENT, LLC position in IBIO

IBIO INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 5,357,088 shares of IBIO (IBIO INC) in its Q3 2026 13F filing — a position valued at US$6.3M, representing 0.81% of its reported portfolio and ranking #32 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed IBIO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)5.36M sh
Reported value held$6.32M
Portfolio Weight0.81%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's IBIO position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in IBIO in Q4 2025 at 106,000 shares (US$205K). The position peaked in Q3 2026 at 5,357,088 shares, worth US$6.3M. Across 4 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,357,088 shares valued at US$6.3M — an increase of 1,836,598 shares quarter over quarter.. Notable position changes include a 113% increase in Q1 2026 (shares fell 8% over the following quarter), a 1458% increase in Q2 2026 (shares fell 33% over the following quarter), a 52% increase in Q3 2026 (shares fell 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 106.00K $204.58K New
Q1 2026 226.00K $429.40K Add
Q2 2026 3.52M $6.16M Add
Q3 2026 5.36M $6.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBIO and 13F data

IBIO (IBIO INC) is a Health Care company. 47 other funds we track also report a position in IBIO — the largest reported positions include Cormorant Asset Management, LP (US$6.2M), Frazier Life Sciences Management, L.P. (US$3.4M), Sio Capital Management, LLC (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBIO

All IBIO fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held IBIO?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed IBIO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in IBIO?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 5.36M shares of IBIO (IBIO INC), valued at $6.32M, representing 0.81% of its reported portfolio and ranking #32.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling IBIO?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in IBIO. The position peaked in Q3 2026 at 5.36M shares.

Which other funds hold IBIO?

Other major institutional holders of IBIO include Cormorant Asset Management, LP, Frazier Life Sciences Management, L.P., Sio Capital Management, LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.